EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada

Alexandre Campeau Calfat iD, Maude Gosselin iD, Caroline Sirois iD

Basic & Clinical Pharmacology & Toxicology · 2025-06 · 136 (6)

DOI: 10.1111/bcpt.70050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 02.05.2025. Verfasst von Alexandre Campeau Calfat und 2 weiteren Autor:innen. Beteiligte Einrichtung: VITAM-Sustainable Health Research Center, Quebec, Canada. Hauptthemen laut MEDLINE: Deprescriptions, Pharmacists, Community Pharmacy Services, Reimbursement Mechanisms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deprescribing is a patient‐centred process in which a healthcare professional reduces or stops medications to improve health outcomes. Since late 2022, community pharmacists in Québec, Canada, have been able to bill for deprescribing interventions, enabling more robust deprescribing research in large cohort studies.

Objective

This study aimed to assess the prevalence of deprescribing claims in Québec community pharmacies from January 1, 2023, to November 30, 2024, and to identify the most commonly deprescribed medication classes.

Methods

We analysed the total number of deprescribing claims submitted by pharmacists during this period and categorized deprescribed medications using the American Hospital Formulary Service classification.

Findings

Over 90 000 claims were submitted for deprescribing interventions, with most involving central nervous system medications. Although the number of claims increased over time, the overall volume remained modest.

Conclusion

While limitations remain, such as the gradual adoption of billing interventions, Québec's reimbursement model for deprescribing interventions provides an important framework for research, offering a mechanism to study deprescribing in real‐world settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsPharmacistsCommunity Pharmacy ServicesReimbursement MechanismsQuebecHumans

Stichwörter der Autor:innen

administrative claimscommunity pharmacy servicesdeprescribingpharmacistpharmacy practice

Autor:innen und Institutionen

  • VITAM-Sustainable Health Research Center, Quebec, Canada.
  • Faculty of Pharmacy, Université Laval, Quebec, Canada.
  • Quebec National Institute of Public Health, Quebec, Canada.

ORCID-Profile: Alexandre Campeau Calfat, Maude Gosselin, Caroline Sirois

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Calfat, A. C., Gosselin, M., & Sirois, C. (2025). Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada. Basic & Clinical Pharmacology & Toxicology, 136(6). https://doi.org/10.1111/bcpt.70050

Vancouver

Calfat AC, Gosselin M, Sirois C. Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada. Basic & Clinical Pharmacology & Toxicology. 2025;136(6). doi:10.1111/bcpt.70050

BibTeX
@article{Calfat2025,
  author = {Calfat, Alexandre Campeau and Gosselin, Maude and Sirois, Caroline},
  title = {Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {136},
  number = {6},
  doi = {10.1111/bcpt.70050}
}
Kostenlos starten →